Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 115,553 | 25,208 | -15,567 | -18,010 | -39,865 |
| Depreciation Amortization | -207 | 735 | 2,558 | 11,868 | 14,231 |
| Income taxes - deferred | -87,767 | 0 | N/A | N/A | N/A |
| Accounts receivable | 2,342 | -11,207 | 2,525 | -4,298 | -12,677 |
| Accounts payable and accrued liabilities | 3,508 | -618 | 5,953 | N/A | N/A |
| Other Working Capital | 3,125 | -7,790 | -26 | -11,108 | 29,639 |
| Other Operating Activity | 9,393 | 23,658 | 2,574 | 13,445 | 21,121 |
| Operating Cash Flow | $45,947 | $29,986 | $-1,983 | $-8,103 | $12,449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,019 | -368 | -1,664 | -1,407 | -2,527 |
| Purchase Of Investment | -394,517 | -282,395 | -148,135 | -165,405 | -193,111 |
| Sale Of Investment | 327,227 | 198,103 | 139,568 | 156,787 | 169,040 |
| Purchase Sale Intangibles | N/A | -25,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -25,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-68,309 | $-109,660 | $-10,231 | $-10,025 | $-26,598 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,264 | 107,126 | 5,251 | 7,751 | 4,374 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -283 |
| Financing Cash Flow | $6,264 | $107,126 | $5,251 | $7,751 | $4,091 |
| Exchange Rate Effect | -1 | -38 | 42 | 5 | N/A |
| Beginning Cash Position | 61,749 | 34,335 | 41,256 | 51,628 | 60,901 |
| End Cash Position | 45,650 | 61,749 | 34,335 | 41,256 | 50,843 |
| Net Cash Flow | $-16,099 | $27,414 | $-6,921 | $-10,372 | $-10,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,947 | 29,986 | -1,983 | -8,103 | 12,449 |
| Capital Expenditure | -1,019 | -368 | -1,664 | -1,407 | -2,527 |
| Free Cash Flow | 44,928 | 29,618 | -3,647 | -9,510 | 9,922 |